Navigation Links
Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
Date:10/27/2009

DENVER, Oct. 27 /PRNewswire/ -- A Denver ophthalmologist recently became the first in Colorado to implant a special type of lens during cataract surgery, raising the bar for patient care in the state while increasing the quality of life for his patients.

Dr. Paul Cutarelli, director of Cutarelli Vision in Denver and Fort Collins, said he implanted an advanced nanoFLEX lens in October in the eye of a 70-year-old man whose cataracts in his left eye were so bad he couldn't read any more. Manufactured by STAAR Surgical, the revolutionary lens offers better quality of vision at night, filters ultraviolet light and is made of a high-tech material so close to the human lens that it's easily tolerated by the eye, greatly lowering inflammation complications.

His patient was a retiree who didn't want to lose his active lifestyle, one that includes riding his Harley with his girlfriend, Cutarelli said.

"He waited until I got on his insurance plan," Cutarelli said. "He didn't want anyone else to do the cataract surgery and wanted to have good reading vision in that eye."

The procedure in the patient's left eye took about 10 minutes, during which Cutarelli removed the bad lens and replaced it with the implant.

Just a few hours later, the patient called the doctor from home and told him he could read clearly and saw better out of his left eye than his right one.

The news was part of what makes the doctor's work so rewarding. And the special lens has a very high patient satisfaction rate, he said.

"It's fantastic to work with patients like this because I can help them stay active. This is a quality of life issue. Without this lens, this guy wouldn't be able to live the full life that he enjoys."

The procedure is just one of many "firsts" for Cutarelli in Colorado. He also was the first to use the lens in northern Colorado at his Fort Collins practice. That surgery also took place in October. His patient is a Wal-Mart greeter whose vision is now 20/20 and saw vibrant colors for the first time in many years.

He was also the first to use Intacs to fight keratoconus, a disease that causes debilitating astigmatisms and fluctuating vision problems in patients. Intacs are plastic rings implanted under the eye's outer most layer, the cornea, and correct its distorted shape caused by pressure problems associated with the disease.

Cutarelli has also done a great deal of published research, always staying abreast of the newest trends and technologies in vision correction. He was a coinvestigator during more than 15 FDA clinical trials for excimer lasers, the biggest developments in laser vision surgery to appear in the last decade. His work has also appeared in numerous scientific publications reviewed by his peers, including Ophthalmology and Current Eye Research, as well as several book chapters on laser eye surgery.

An expert in correcting refractive and presbyopic problems, Cutarelli has performed more than 60,000 LASIK and LASEK procedures in Colorado. He's one of only a few who've had one-year fellowships in refractive and corneal surgeries, including transplants, and is certified by the American Board of Ophthalmology.

Before he opened his practice in Denver, Cutarelli directed refractive surgery and was an assistant ophthalmology professor at University Hospitals in Cleveland, Ohio. There, he founded the hospitals' refractive surgery fellowship training program. And he taught medical students at his alma mater, Case Western Reserve University.

His expertise has been sought after internationally, at London's Moorfields Eye Hospital and the Al Noor Hospital in the United Arab Emirates.

www.denverlasik.com

www.fortcollinsvision.com

Source: Cutarelli Vision

    CONTACT:
    Cutarelli Vision
    7887 E Belleview Ave
    Denver (Englewood), CO    80111
    (303) 486-2020   

SOURCE Cutarelli Vision


'/>"/>
SOURCE Cutarelli Vision
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017 Now in its seventh ... that are most successful at developing and commercialising innovation. ... The Index ... same molecule to two different companies in early phase, which ... systematic, objective analysis of each company,s performance between 2011 and 2016, the ...
(Date:2/27/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today ... as President and Chief Executive Officer (CEO) and member of ... succeeds Richard Love , interim President and CEO who ... Dr. Craig has over 20 years of experience in hematology, ... Europe . "On behalf of CTI ...
(Date:2/27/2017)... , Feb 27, 2017 The ... by NATO for use at the security level RESTRICTED. The ... the NATO organization for the communication of classified information. ... Sectra and ... with an eavesdrop-secure smartphone solution. Sectra Tiger/R is developed by ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... wholesale distribution in North America, today announced it would be offering some it’s ... which prides itself on crafting quality and unique baby clothing/feeding products, will team ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and ... the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... (PD) patients after receiving cognitive rehabilitation, according to a study released today at ... known that cognitive rehabilitation programs are proven to be effective in improving cognitive ...
(Date:2/25/2017)... ... 25, 2017 , ... FCPX users now have the ability to sharpen a ... ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, ... spectrum tools users can visually see the color range effected with ease all within ...
Breaking Medicine News(10 mins):